With these devices, LifeMD is setting a new standard in virtual care by providing clinicians with near real-time and actionable patient data that can drive compliance, enhance clinical decision-making, encourage preventive healthcare, and, most importantly, improve long-term outcomes
[Accessed on 11 June 2026] Orforglipron, an oral small-molecule GLP-1 receptor agonist, for the treatment of obesity in people with type 2 diabetes (ATTAIN-2) (2025)
Call your doctor if this occurs as you might need to adjust your dose
Treatment frequency varies based on individual goals and initial consultation recommendations
According to Dana DiRenzo, MD, MHS, assistant professor of clinical medicine in rheumatology at the University of Pennsylvania Perelman School of Medicine, blocking B cells may have significant benefit, especially for those with high immunological disease activity, based on the pathophysiology of Sjgrens disease